|
Market Closed -
Australian S.E.
11:40:07 24/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.009000 AUD | -10.00% |
|
-10.00% | -40.00% |
| 24/08 | Acrux Limited Announces Appointment of Jolanta Airey as Chief Medical Officer | CI |
| 17/08 | Acrux Limited - Special Call |
| Market Cap | 62.73L 44.85L 38.44L 35.98L 32.87L 62.1L 43Cr 4.25Cr 1.66Cr 22Cr 1.68Cr 1.65Cr 71Cr | P/E 2024 |
-3.44x | P/E 2025 | -0.95x |
|---|---|---|---|---|---|
| Enterprise Value | 90.45L 64.66L 55.43L 51.88L 47.39L 89.54L 62Cr 6.14Cr 2.39Cr 31Cr 2.43Cr 2.38Cr 102.86Cr | EV / Sales 2024 |
4.09x | EV / Sales 2025 | 7.81x |
| Free-Float |
78.27% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Acrux Limited
| 23/22/23 | Acrux : Application for quotation of securities - ACR | PU |
| 14/22/14 | Acrux : Application for quotation of securities - ACR | PU |
| 16/22/16 | Acrux : Application for quotation of securities - ACR | PU |
| 25/22/25 | Acrux : Updated Board Charter | PU |
| 25/22/25 | Acrux : Application for quotation of securities - ACR | PU |
| 1 day | -10.00% | ||
| 1 week | -10.00% | ||
| Current month | -10.00% | ||
| 1 month | -25.00% | ||
| 6 months | -35.71% | ||
| Current year | -40.00% |
| 1 week | 0.01 | 0.01 | |
| 1 month | 0.01 | 0.01 | |
| Current year | 0.01 | 0.02 | |
| 1 year | 0.01 | 0.02 | |
| 3 years | 0.01 | 0.1 | |
| 5 years | 0.01 | 0.14 | |
| 10 years | 0.01 | 0.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Warmbrunn
CEO | Chief Executive Officer | - | 01/06/2025 |
Joanna Johnson
DFI | Director of Finance/CFO | - | 21/06/2021 |
Jolanta Airey
CTO | Chief Tech/Sci/R&D Officer | - | 24/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Ross Dobinson
CHM | Chairman | 74 | 01/01/2006 |
Timothy Oldham
BRD | Director/Board Member | - | 01/10/2013 |
Geoff Brooke
BRD | Director/Board Member | 70 | 01/06/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -10.00% | -10.00% | -35.71% | -80.43% | 42.27L | ||
| +0.40% | -1.04% | +16.34% | +69.97% | 4.77TCr | ||
| +0.12% | +1.50% | +51.38% | +122.20% | 4.03TCr | ||
| +0.40% | -0.83% | -9.73% | +16.84% | 1.21TCr | ||
| -1.45% | -2.77% | +11.63% | +71.04% | 1.17TCr | ||
| +0.19% | +0.58% | +30.98% | +158.71% | 918.98Cr | ||
| +3.49% | +2.54% | +24.70% | +43.56% | 757.14Cr | ||
| -0.16% | +0.58% | +47.14% | -11.83% | 723.59Cr | ||
| +3.14% | +3.12% | +23.40% | +215.25% | 683.65Cr | ||
| -3.24% | -9.40% | -40.05% | +18.52% | 541.95Cr | ||
| Average | -0.71% | -1.22% | +12.01% | +62.38% | 1.48TCr | |
| Weighted average by Cap. | +0.29% | -0.65% | +24.48% | +84.92% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 50.91L 36.39L 31.2L 29.2L 26.67L 50.4L 35Cr 3.45Cr 1.34Cr 17Cr 1.37Cr 1.34Cr 58Cr | 11.9L 9L 7L 7L 6L 11.78L 8.14Cr 80.71L 31.4L 4.09Cr 31.94L 31.25L 14Cr |
| Net income | -58L -41.46L -35.54L -33.27L -30.39L -57.41L -40Cr -3.93Cr -1.53Cr -20Cr -1.56Cr -1.52Cr -66Cr | -59.45L -42.5L -36.43L -34.1L -31.15L -58.85L -41Cr -4.03Cr -1.57Cr -20Cr -1.6Cr -1.56Cr -68Cr |
| Net Debt | 8L 5L 5L 4L 4L 8L 5.19Cr 51.48L 20.02L 2.61Cr 20.37L 19.93L 8.63Cr | 27.72L 19.82L 16.99L 15.9L 14.52L 27.44L 19Cr 1.88Cr 73.13L 9.53Cr 74.41L 72.79L 32Cr |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | A$0.009000 | -10.00% | 15,67,387 |
| 21/26/21 | A$0.0100 | 0.00% | 5,425 |
| 20/26/20 | A$0.0100 | +11.11% | 7,37,986 |
| 19/26/19 | A$0.009000 | -10.00% | 20,48,103 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ACR Stock
Select your edition
All financial news and data tailored to specific country editions

















